ATE129286T1 - Klonierung von streptomyces avermitilis genen zur biosynthese von avermectin und verfahren zu ihrer verwendung. - Google Patents

Klonierung von streptomyces avermitilis genen zur biosynthese von avermectin und verfahren zu ihrer verwendung.

Info

Publication number
ATE129286T1
ATE129286T1 AT90303300T AT90303300T ATE129286T1 AT E129286 T1 ATE129286 T1 AT E129286T1 AT 90303300 T AT90303300 T AT 90303300T AT 90303300 T AT90303300 T AT 90303300T AT E129286 T1 ATE129286 T1 AT E129286T1
Authority
AT
Austria
Prior art keywords
avermectin
biosynthesis
streptomyces avermitilis
cloning
disclosed
Prior art date
Application number
AT90303300T
Other languages
English (en)
Inventor
Keith M Gewain
Philip S Paress
Douglas J Macneil
Carolyn L Ruby
Stanley S Streicher
Tanya Macneil
Original Assignee
Merck & Co Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US07/490,723 external-priority patent/US5252474A/en
Application filed by Merck & Co Inc filed Critical Merck & Co Inc
Application granted granted Critical
Publication of ATE129286T1 publication Critical patent/ATE129286T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/10—Processes for the isolation, preparation or purification of DNA or RNA
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • C12N15/52—Genes encoding for enzymes or proenzymes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/74—Vectors or expression systems specially adapted for prokaryotic hosts other than E. coli, e.g. Lactobacillus, Micromonospora
    • C12N15/76—Vectors or expression systems specially adapted for prokaryotic hosts other than E. coli, e.g. Lactobacillus, Micromonospora for Actinomyces; for Streptomyces
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/10—Transferases (2.)
    • C12N9/1003—Transferases (2.) transferring one-carbon groups (2.1)
    • C12N9/1007—Methyltransferases (general) (2.1.1.)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/88—Lyases (4.)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P17/00—Preparation of heterocyclic carbon compounds with only O, N, S, Se or Te as ring hetero atoms
    • C12P17/18—Preparation of heterocyclic carbon compounds with only O, N, S, Se or Te as ring hetero atoms containing at least two hetero rings condensed among themselves or condensed with a common carbocyclic ring system, e.g. rifamycin
    • C12P17/181—Heterocyclic compounds containing oxygen atoms as the only ring heteroatoms in the condensed system, e.g. Salinomycin, Septamycin
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P19/00—Preparation of compounds containing saccharide radicals
    • C12P19/44—Preparation of O-glycosides, e.g. glucosides
    • C12P19/60—Preparation of O-glycosides, e.g. glucosides having an oxygen of the saccharide radical directly bound to a non-saccharide heterocyclic ring or a condensed ring system containing a non-saccharide heterocyclic ring, e.g. coumermycin, novobiocin
    • C12P19/62—Preparation of O-glycosides, e.g. glucosides having an oxygen of the saccharide radical directly bound to a non-saccharide heterocyclic ring or a condensed ring system containing a non-saccharide heterocyclic ring, e.g. coumermycin, novobiocin the hetero ring having eight or more ring members and only oxygen as ring hetero atoms, e.g. erythromycin, spiramycin, nystatin
    • C12P19/623—Avermectin; Milbemycin; Ivermectin; C-076

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • Organic Chemistry (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • General Health & Medical Sciences (AREA)
  • Microbiology (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Plant Pathology (AREA)
  • Biophysics (AREA)
  • Physics & Mathematics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Saccharide Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
AT90303300T 1989-03-31 1990-03-28 Klonierung von streptomyces avermitilis genen zur biosynthese von avermectin und verfahren zu ihrer verwendung. ATE129286T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US33114689A 1989-03-31 1989-03-31
US07/490,723 US5252474A (en) 1989-03-31 1990-03-14 Cloning genes from Streptomyces avermitilis for avermectin biosynthesis and the methods for their use

Publications (1)

Publication Number Publication Date
ATE129286T1 true ATE129286T1 (de) 1995-11-15

Family

ID=26987612

Family Applications (1)

Application Number Title Priority Date Filing Date
AT90303300T ATE129286T1 (de) 1989-03-31 1990-03-28 Klonierung von streptomyces avermitilis genen zur biosynthese von avermectin und verfahren zu ihrer verwendung.

Country Status (9)

Country Link
EP (1) EP0391594B1 (de)
JP (1) JP3063910B2 (de)
AT (1) ATE129286T1 (de)
AU (1) AU626398B2 (de)
CA (1) CA2013524C (de)
DE (1) DE69023036T2 (de)
ES (1) ES2079436T3 (de)
IE (1) IE69375B1 (de)
NZ (1) NZ233116A (de)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0528452A1 (de) * 1991-06-19 1993-02-24 Merck & Co. Inc. Immunomycin durch enzymatische und/oder mikrobielle Methylation hergestellt
FI942725A7 (fi) * 1993-12-16 1995-06-17 Pfizer Haaraketjuista alfaketohappodenydrogenaasikompleksia koodaavia geenejä Streptomyces avermitiliksesta
CN1297485A (zh) * 1998-02-13 2001-05-30 辉瑞产品公司 介导除虫菌素b2:b1比例的除虫链霉菌基因
US6248579B1 (en) 1998-02-13 2001-06-19 Pfizer Inc Streptomyces avermitilis gene directing the ratio of B2:B1 avermectins
GB9814622D0 (en) * 1998-07-06 1998-09-02 Biotica Tech Ltd Polyketides,their preparation,and materials for use therein
DE19838848A1 (de) 1998-08-26 2000-03-02 Weber & Weber Gmbh & Co Kg Pyrrolizidinalkaloidfreie Petasites enthaltende Zusammensetzung
US6197591B1 (en) 1998-09-14 2001-03-06 Pfizer Inc. Streptomyces avermitilis regulatory genes for increased avermectin production
JP2000245457A (ja) * 1999-02-24 2000-09-12 Kitasato Inst:The エバーメクチンアグリコン合成酵素遺伝子
CA2380639A1 (en) * 1999-07-30 2001-02-08 Merck & Co., Inc. Cloning of the <i>streptomyces avermitilis</i> genes for glycosylation of avermectin aglycones
ATE341632T1 (de) 1999-08-12 2006-10-15 Pfizer Prod Inc Streptomyces avermitilis gen zum regulieren des verhältnisses der b2:b1 avermectinen
US20040101936A1 (en) * 2000-02-24 2004-05-27 Hirofumi Endo Process for producing avermectin derivative

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE434277B (sv) 1976-04-19 1984-07-16 Merck & Co Inc Sett att framstella nya antihelmintiskt verkande foreningar genom odling av streptomyces avermitilis
US4429042A (en) 1978-09-08 1984-01-31 Merck & Co., Inc. Strain of Streptomyces for producing antiparasitic compounds
US4703009A (en) * 1983-03-08 1987-10-27 Merck & Co., Inc. RDNA cloning vector pVE1, deletion and hybrid mutants and recombinant derivatives thereof products and processes
DE3477936D1 (en) * 1983-03-08 1989-06-01 Merck & Co Inc Recombinant dna cloning vector pve1, deletion and hybrid mutants, and recombinant derivatives thereof, products and processes
EP0463707A1 (de) * 1985-12-17 1992-01-02 Lubrizol Genetics Inc. Herstellung von Polyketid-Antibiotika

Also Published As

Publication number Publication date
NZ233116A (en) 1994-09-27
EP0391594B1 (de) 1995-10-18
JPH0315391A (ja) 1991-01-23
EP0391594A2 (de) 1990-10-10
AU626398B2 (en) 1992-07-30
DE69023036T2 (de) 1996-06-13
JP3063910B2 (ja) 2000-07-12
IE901184L (en) 1990-09-30
AU5244590A (en) 1990-10-04
EP0391594A3 (de) 1992-01-02
IE69375B1 (en) 1996-09-04
ES2079436T3 (es) 1996-01-16
DE69023036D1 (de) 1995-11-23
CA2013524C (en) 2005-12-06
CA2013524A1 (en) 1990-09-30

Similar Documents

Publication Publication Date Title
Kreft et al. Recombinant plasmids capable of replication in B. subtilis and E. coli
Sun et al. Control of transcription of the Bacillus subtilis spoIIIG gene, which codes for the forespore-specific transcription factor sigma G
EP0329822A3 (en) Nucleic acid amplification process
DK120091D0 (da) Tripelstrenget nukleinsyre og anvendelse heraf
ATE129286T1 (de) Klonierung von streptomyces avermitilis genen zur biosynthese von avermectin und verfahren zu ihrer verwendung.
ES2119744T3 (es) Nitrato reductasa como marcador de acremonium chrysogenum.
CA2065003A1 (en) Enhanced nucleic acid amplification process
MY114656A (en) Mycobacteria probes
AU641159B2 (en) Method for the synthesis of ribonucleic acid (RNA)
DK0522880T3 (da) Gensekvenser som koder for flavonoid pathway enzymer og anvendelse
DE3629890A1 (de) Mikroorganismen und plasmide fuer die 2,4-dichlorphenoxyessigsaeure (2,4-d)-monooxigenase - bildung und verfahren zur herstellung dieser plasmide und staemme
AU3743395A (en) Novel pesticidal proteins and strains
AU9058091A (en) Preparation of nucleic acid samples
RU94046200A (ru) Последовательности днк, производные последовательностей днк, плазмиды, способ применения последовательностей, способ применения плазмид, трансгенные растения
NZ307444A (en) Polyphenol oxidase genes from lettuce and banana
WO1999042589A3 (en) Insecticidal toxins from photorhabdus
JPS55104888A (en) Plasmid of stable plural copies
WO1994000472A3 (en) Trivalent synthesis of oligonucleotides containing stereospecific alkylphosphonates and arylphosphonates
US5079151A (en) Production of branched RNA-linked multi-copy single-stranded DNA using permeabilized cells
KR890700677A (ko) 바실러스 튜린지엔시스 p-2 독소유전자, 단백질 및 관련 살충제 조성물
DK0857220T3 (da) Sekvensmodifikation af oligonucleotidprimere til manipulering af ikke-templateret nucleotidaddition
EP0712933A3 (de) Für die FseI Restriktionsendonuklease kodierende, isolierte DNA und Verfahren zu ihren Herstellung
AU3905893A (en) Plant resistant to two or more viruses and preparation thereof
EP0147145A3 (de) Streptomycete Wirtzellen mit beschränkter Restriktionsaktivität
EP4544037B1 (de) Crispr-cas9 basierte linearisierung von plasmid dna-templaten

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties